SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-19-024665
Filing Date
2019-02-01
Accepted
2019-02-01 07:16:39
Documents
4
Group Members
BOWFIN ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d644229dsctota.htm SC TO-T/A 36663
2 EX-(A)(5)(B) d644229dex99a5b.htm EX-99.(A)(5)(B) 17156
3 GRAPHIC g621963g0131171938699.jpg GRAPHIC 4234
4 GRAPHIC g621963g0131171938777.jpg GRAPHIC 3374
  Complete submission text file 0001193125-19-024665.txt   66245
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88267 | Film No.: 19557705
SIC: 2834 Pharmaceutical Preparations